Coya Therapeutics (COYA) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to -$0.13.
- Coya Therapeutics' EPS (Weighted Average and Diluted) rose 5000.0% to -$0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.11, marking a year-over-year decrease of 7076.92%. This contributed to the annual value of -$0.98 for FY2024, which is 2360.75% down from last year.
- Coya Therapeutics' EPS (Weighted Average and Diluted) amounted to -$0.13 in Q3 2025, which was up 5000.0% from -$0.36 recorded in Q2 2025.
- In the past 5 years, Coya Therapeutics' EPS (Weighted Average and Diluted) registered a high of $0.15 during Q4 2023, and its lowest value of -$0.44 during Q1 2025.
- In the last 3 years, Coya Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.28 in 2023 and averaged -$0.25.
- In the last 5 years, Coya Therapeutics' EPS (Weighted Average and Diluted) tumbled by 27850.33% in 2024 and then skyrocketed by 5000.0% in 2025.
- Coya Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at $0.15 in 2023, then plummeted by 278.5% to -$0.27 in 2024, then soared by 51.45% to -$0.13 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.13 in Q3 2025, compared to -$0.36 in Q2 2025 and -$0.44 in Q1 2025.